Skip to main content
placeholder image

Deflexifol (a novel formulation of 5FU): Phase 1 dose escalation study of infusional and bolus schedules after failure of standard treatment.

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)
  •   Brungs, Daniel
  •   Clingan, Phillip (external author)
  •   De Souza, Paul (external author)
  •   Ranson, Marie

Publication Date


  • 2017

Citation


  • Clingan, P. R., Ackland, S. P., Ranson, M., Brungs, D., Aghmesheh, M., Tafreshi, A., . . . De Souza, P. L. (2017). Deflexifol (a novel formulation of 5FU): Phase 1 dose escalation study of infusional and bolus schedules after failure of standard treatment.. Journal of Clinical Oncology, 35(15_suppl), 2529. doi:10.1200/jco.2017.35.15_suppl.2529

Web Of Science Accession Number


Start Page


  • 2529

End Page


  • 2529

Volume


  • 35

Issue


  • 15_suppl

Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)
  •   Brungs, Daniel
  •   Clingan, Phillip (external author)
  •   De Souza, Paul (external author)
  •   Ranson, Marie

Publication Date


  • 2017

Citation


  • Clingan, P. R., Ackland, S. P., Ranson, M., Brungs, D., Aghmesheh, M., Tafreshi, A., . . . De Souza, P. L. (2017). Deflexifol (a novel formulation of 5FU): Phase 1 dose escalation study of infusional and bolus schedules after failure of standard treatment.. Journal of Clinical Oncology, 35(15_suppl), 2529. doi:10.1200/jco.2017.35.15_suppl.2529

Web Of Science Accession Number


Start Page


  • 2529

End Page


  • 2529

Volume


  • 35

Issue


  • 15_suppl